Journals / Ondokuz Mayıs Üniv. Diş Hekimliği Derg. / 2009 / Cilt: 10 - Sayı: 2

Anelgesic choice for dental pain

Dental ağrılarda analjezik seçimi

Pages
30–40
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It is of paramount importance for the dentists to the designate proper medication for the experienced level of pain, and to be able to select appropriate combinations considering the different pharmacokinetics and mechanisms of action.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Inefficient management of dental pain may result in avoidance or postponement of treatment by the patient.
📊
Key Findings & Data:Conventional analgesics are classified as opioids and nonopioids replacing the older nomenclature for ‘‘narcotics’’ and ‘‘non-narcotics’’.
💡
Conclusion & Impact:It is of paramount importance for the dentists to the designate proper medication for the experienced level of pain, and to be able to select appropriate combinations considering the different pharmacokinetics and mechanisms of action.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Analjezikler · opioid · Anti-enflamatuvar ajanlar

Abstract

Inefficient management of dental pain may result in avoidance or postponement of treatment by the patient. Therefore, proper pain management improves clinical outcomes. Conventional analgesics are classified as opioids and nonopioids replacing the older nomenclature for ‘‘narcotics’’ and ‘‘non-narcotics’’. Nonopioids include acetaminophen and the nonsteroidal anti-inflammatory drugs (NSAIDs) which inhibit prostaglandin synthesis. On the other hand, opioids such as morphine, display agonistic properties on specific receptors. Diverse mechanisms of action may provide more efficient pain relief by lower dose combinations as well as improving recovery period and reducing side effects. It has been documented that opioid-acetominophen or NSAID-opioid combinations are effective in acute dental pain. It is of paramount importance for the dentists to the designate proper medication for the experienced level of pain, and to be able to select appropriate combinations considering the different pharmacokinetics and mechanisms of action.

Özet

Dental ağrının giderilmesini ya da azaltılmasını sağlayan ilaçların etkin biçimde kullanılması, ağrı yakınması olan bir hastanın tedavisini ve dolayısıyla klinik sonuçlarını da olarak etkilemektedir. Ağrı kesiciler genel olarak opiodler ve nonopioidler olarak ikiye ayrılır; bu terimler eskiden kullanılan narkotikler ve nonnarkotiklerin yeni isimleridir. Nonopioidler, prostoglandin sentezini inhibe eden asetaminofen ve non-steroid anti-enflamatuar ilaçları (NSAİ) içermektedir. Opioidler ise spesifik reseptörlerde agonist etki gösteren morfin ile temsil edi lmektedir . Bahsedi len anal jeziklerin etki mekanizmalarının farklı olması, daha düşük dozlarda kombine kullanımları ile daha etkin analjezi elde edilmesini sağlamaktadır. Analjeziklerin kombine terapisi dental ağrının giderilmesinde etkiyi arttırmakta, yan etkileri azaltmakta ve iyileşme zamanını kısaltmaktadır. Özellikle opioid-asetaminofen kombinasyonu ile klasik NSAİ-opioid kombinasyonlarının akut dental ağrılarda etkin oldukları gösterilmiştir. Hekimler için önemli olan, hangi ağrı düzeyinde hangi ilacın kullanılacağını bilmek ve özellikle tek bir ilacın yetersiz kaldığı şiddetli ağrılarda ilaç kombinasyonlarını her kategorinin farmakolojik özellikleri ve etki mekanizmalarını göz önünde bulundurarak oluşturabilmektir.

🔖

Cite This Article

ERGÜN, S., GÜNERİ, P. (2009). Anelgesic choice for dental pain. Ondokuz Mayıs Üniv. Diş Hekimliği Derg., Cilt: 10 - Sayı: 2, 30–40. https://ajindex.com/articles/293168

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (19)

  1. Mehlisch DR. The efficacy of combination analgesic therapy in relieving dental pain. J Am Dent Assoc. 2002; 133: 861-71
  2. Barkin RL. Acetaminophen, Aspirin, or Ibuprofen in combination analgesic products. Am J Ther. 2001; 8: 433-42
  3. Litkowski LJ, Christensen SE, Adamson DN, Van Dyke T, Han SH, Newman KB. Analgesic efficacy and tolerability of oxycodone 5 mg/ Ibuprofen 400 mg compared with those of oxycodone 5 mg/ Acetaminophen 325 mg and Hydrocodone 7.5 mg/ Acetaminophen 500 mg in patients with moderate to severe postoperative pain: a randomized, double-blind, placebo- controlled, single-dose, paralel-group study in a dental pain model. Clin Ther. 2005; 27: 418-29
  4. Carr DB, Goudas LC. Acute pain. Lancet. 1999; 353: 2051-58
  5. Bonner P. Update on pain management. Dent Today. 1997; 16: 60-5
  6. Becker DE, Phero JC. Drug therapy in dental practice: Nonopioid and opioid analgesics. Anesth Prog. 2005; 52: 140-9
  7. Erdine S. Ağrı mekanizmaları ve ağrıya genel yaklaşım. In: Erdine S: Ağrı 3. Baskı. Nobel Tıp Kitabevleri, İstanbul, 2007; 37-49
  8. Moore PA, Gage TW, Hersh EV, Yagiela JA, Haas DA. Adverse drug interactions in dental practice. Professional and educational implications. J Am Dent Assoc. 1999; 130: 47-54
  9. Keene JJ, Galasko GT, Land MF. Antidepressant use in psychiatry and medicine. Importance for dental practice. J Am Dent Assoc. 2003; 134: 71- 79
  10. Malmberg AB, Yaksh TL. Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition. Science. 1992; 257: 1276-9
  11. Stein CS. The control of pain in peripheral tissue by opioids. N Engl J Med. 1995; 332: 1685-1690
  12. Raffa RB. Pharmacology of oral combination analgesics: rational therapy for pain. J Clin Pharm Ther. 2001; 26: 257-64
  13. Hersh EV, Moore PA. Adverse drug interactions in dentistry. Periodontol 2000 2008; 46: 109-142
  14. Maddrey WC. Hepatic effects of acetaminophen: enhanced toxicity in alcoholics. J Clin Gastroenterol. 1987; 9: 180-85
  15. Haas DA. An update on analgesic fort he management of acute postoperative dental pain. J Can Dent Assoc. 2002; 68: 476-82
  16. Langford RM. Pain management today-what have we learned? Clin Rheumatol. 2006; 25: S2-S8
  17. Vane J. Aspirin and other anti-inflammatory drugs. Thorax. 2000; 55: 3-9
  18. Çizmeci P, Babacan CA. Ağrı tedavisinde kullanılan ilaçlar. Turkiye Klinikleri J Surg Med Sci. 2007; 3: 22-33
  19. Mohan S, Epstein JB. Carcinogenesis and cyclooxygenase: the potential role o